NCT06727097 Post-Stroke Sensory Reweighting on Walking and Balance Outcomes
| NCT ID | NCT06727097 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cincinnati |
| Condition | Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 45 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 45 participants in total. It began in 2024-11-01 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this proof-of-concept study is to longitudinally track the development of post-stroke sensory reweighting (PSR), identify associated structural neuroanatomical correlates, and investigate their relationship to walking and fall outcomes.
Eligibility Criteria
Inclusion Criteria: 1. First ever clinical stroke 2. Stroke due to ischemia 3. Age 18 years or older 4. Ability to consent by patient (not surrogate), any time prior to acute hospital discharge Exclusion Criteria: 1. Pre-stroke dependence (modified Rankin Scale score of 3 or more) 2. Isolated brainstem or cerebellar stroke 3. Bilateral acute strokes 4. Co-enrollment in a trial of an intervention through six-month follow-up 5. Inability to maintain follow-up with study procedures through six-month follow-up 6. Contraindication to non-contrast MRI 7. Low likelihood of survival beyond the acute hospitalization, such as malignant cerebral edema 8. Pre-existing co-morbid conditions that significantly affects vision, somatosensory function, vestibular system, orthostasis, coordination or mobility 9. Post stroke mRS\>4 or discharge to hospice
Contact & Investigator
Oluwole Awosika, MD, MSCR
PRINCIPAL INVESTIGATOR
University of
Frequently Asked Questions
Who can join the NCT06727097 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06727097 currently recruiting?
Yes, NCT06727097 is actively recruiting participants. Contact the research team at awosikoe@ucmail.uc.edu for enrollment information.
Where is the NCT06727097 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT06727097 clinical trial?
NCT06727097 is sponsored by University of Cincinnati. The principal investigator is Oluwole Awosika, MD, MSCR at University of. The trial plans to enroll 45 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.